Over 2,000 of these have been purchased in the last month…
Intel (INTC) stock is up about 9%, at the time of writing, Tuesday afternoon, Jan. 13, thanks to KeyBanc raising its price target to $60, according to Yahoo Finance. The company’s Q4 earnings are near and will be released on January 22. Intel’s competitors, AMD and ARM…
The Great Freight Recession has been challenging for trucking and logistics companies since it began in early 2022. Shipping companies have faced reduced shipping demand, lower freight rates, and rising costs of labor, fuel, and insurance, which have impacted revenues and profits. In some cases, …
Tesla’s tale about cars that drive themselves is going in circles. A significant new announcement reaches the press, and investors start to fear that the “moat” is narrowing. Then the talk turns back to the laborious process of getting the cars on the road, and Tesla is back to square one…
A new year is often meant to symbolize fresh starts, but for one of America’s most recognizable casual dining brands, 2024 delivered the opposite. Instead of renewal, the year was marked by financial troubles, bankruptcy, and a significant loss of its domestic and international footprints. Founded …
Ford Motor Company (F) wrapped up 2025 with impressive gains. The Detroit automaker saw its shares climb 33%, outpacing Tesla’s performance by a significant margin for the year. Market sentiment shifted dramatically for the maker of America’s bestselling vehicle, the F-Series pickup truck. …
The stock market and investment portfolios are continually evolving. With banks recommending the incorporation of cryptocurrencies in their investments and including artificial intelligence and energy growth stocks, another conversation has extended into the new year: Is energy the key to …
When it comes to your money, the chair of the Federal Reserve has more power than you might think. Credit cards? Check.Student loans? Check.Auto loans? Check. Then there’s the impact on mortgage rates, your stock portfolio, and regulation of the nation’s banking industry. Add the U.S…
Bank of America Global Research upped its rating on Regeneron Pharmaceuticals and its price target to $860 because it has a better view on Eylea HD, Dupixent is growing steadily, and there are several catalysts for 2026. Bank of America Global Research raised its rating on Regeneron …
After roughly 15 months of the Covid pandemic lockdowns, I sat with my laptop outside a Starbucks in West Palm Beach. It seemed like a little thing, but when I realized how long I had been surviving off of drive-thru and pickup, I started to cry…





